Physician

Ramakrishnan Ranganath, MD

According to 2025 Medicare claims, Ramakrishnan Ranganath, MD (NPI: 1225213028) practices interventional cardiology in the Lubbock, TX market, with the plurality of this provider's patient population coming from Lubbock, TX. This provider's primary affiliated billing organization is COVENANT MEDICAL GROUP (NPI: 1376598904; TIN: 752745546) and primary practice location at 79410-1210. Ranganath is affiliated with the Covenant ACO, Inc. (ACO ID: A2021), Caravan Health ACO 43 LLC (ACO ID: A4974), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Ranganath's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,685 traditional Medicare patients, billed 4,873 HCPCS/CPT codes, and received $327,056 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 9,054 prescription claims across 1,059 beneficiaries totaling $1,278,358 in drug costs, led by Eliquis (Apixaban). 2023 DME data shows 11 claims. Open Payments data shows 26 records totaling $458. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $174,424 to $327,056. Similarly, Part D prescription costs have risen steadily, from $117,531 to $1,278,358. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $6,865 and ending at $782.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	931	3,057	$174,424
2016	1,123	3,800	$196,760
2017	1,152	4,429	$241,739
2018	1,310	4,583	$250,905
2019	1,201	4,343	$236,613
2020	1,109	3,721	$190,909
2021	1,405	3,861	$203,378
2022	1,697	4,165	$261,348
2023	1,813	5,395	$403,936
2024	1,685	4,873	$327,056

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	323	2,466	$117,531
2016	409	4,897	$285,203
2017	503	5,812	$391,318
2018	644	6,784	$554,051
2019	698	7,467	$780,416
2020	839	9,130	$990,021
2021	872	9,380	$1,131,965
2022	947	8,610	$1,229,561
2023	1,014	9,078	$1,304,457
2024	1,059	9,054	$1,278,358

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	76	$6,396
2016	N/R	75	$3,536
2017	N/R	47	$1,960
2018	N/R	67	$2,534
2019	N/R	26	$1,472
2020	N/R	84	$5,081
2021	N/R	104	$6,059
2022	N/R	55	$3,305
2023	N/R	11	$998
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	482	500	$84
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	859	1,514	$80
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	202	225	$54
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	533	561	$9
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	318	341	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	830	35,362	$656,767
Entresto	Sacubitril/Valsartan	232	9,191	$175,874
Xarelto	Rivaroxaban	126	5,715	$101,559
Repatha Sureclick	Evolocumab	120	4,346	$83,267
Multaq	Dronedarone Hcl	45	1,920	$50,313

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	26	$458	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ramakrishnan Ranganath, MD?

Tedicare shows public-source Medicare data for Ramakrishnan Ranganath, MD (NPI 1225213028), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ramakrishnan Ranganath, MD have ACO affiliation data?

Ramakrishnan Ranganath, MD is shown with ACO affiliation data for Covenant ACO, Inc. (MSSP, ACO ID A2021), Caravan Health ACO 43 LLC (MSSP, ACO ID A4974), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Ramakrishnan Ranganath, MD?

Ramakrishnan Ranganath, MD is linked to COVENANT MEDICAL GROUP (billing NPI 1376598904) in the available physician profile data.

Does Ramakrishnan Ranganath, MD have Open Payments data?

Ramakrishnan Ranganath, MD has 26 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.